Nikko Asset Management Americas’s Standard BioTools LAB Stock Holding History

Nikko Asset Management Americas’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$407K	Sell	442,784 -3,893,103	-90%	-$4.71M	0.01%	182
2025 Q4	$5.51M	Sell	4,335,887 -1,055,942	-20%	-$1.42M	0.06%	104
2025 Q3	$7.01M	Sell	5,391,829 -764,273	-12%	-$1M	0.07%	99
2025 Q2	$7.33M	Sell	6,156,102 -77,591	-1%	-$86K	0.07%	94
2025 Q1	$6.73M	Sell	6,233,693 -384,701	-6%	-$540K	0.09%	92
2024 Q4	$11.5M	Sell	6,618,394 -2,954,098	-31%	-$5.5M	0.12%	83
2024 Q3	$18.4M	Sell	9,572,492 -1,069,779	-10%	-$2.09M	0.21%	71
2024 Q2	$18.7M	Buy	10,642,271 +1,788,780	+20%	+$4.37M	0.22%	69
2024 Q1	$24M	Buy	+8,853,491	New	+$21.4M	0.24%	64

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Nikko Asset Management Americas's LAB Position: Q1 2026 in Review

Nikko Asset Management Americas reduced its Standard BioTools (LAB) stake by 90% in Q1 2026, selling an estimated $4.71M and leaving 442,784 shares worth $407K. The position accounts for 0.01% of the portfolio, ranked #182.

Nikko Asset Management Americas first reported a position in LAB in Q1 2024 and has held it in 9 quarters since. The position peaked at $24M in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

Nikko Asset Management Americas held 442,784 shares of Standard BioTools worth $407K as of Q1 2026.
Nikko Asset Management Americas sold 3,893,103 Standard BioTools shares in Q1 2026, an estimated $4.71M.
Standard BioTools made up 0.01% of Nikko Asset Management Americas's portfolio in Q1 2026, its #182 holding.
Nikko Asset Management Americas first reported a position in Standard BioTools in Q1 2024 and has held it in 9 quarters since.
Nikko Asset Management Americas's Standard BioTools position peaked at $24M in Q1 2024.
155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Nikko Asset Management Americas's 13F filing for Q1 2026, filed 7 May 2026.